Adhesion Failure during scale-up: inspection-ready documentation pack






Published on 30/12/2025

Dealing with Adhesion Failures During Scale-Up: A Comprehensive Investigation Guide

In the world of pharmaceutical manufacturing, particularly in the development of transdermal drug delivery systems, adherence to quality is non-negotiable. Adhesion failures during scale-up can jeopardize product efficacy and patient safety, leading to significant financial and regulatory repercussions. This article elucidates a structured approach to investigating adhesion failures, guiding QA and QC professionals on how to navigate the complexities of deviation investigations and develop inspection-ready documentation.

By the end of this article, readers will be equipped with practical tools and strategies to identify symptoms, hypothesize causes, conduct thorough investigations, and implement effective corrective and preventive actions (CAPA). You will enhance your ability to manage risk in pharmaceutical operations, ensuring compliance with GMP standards and readiness for regulatory scrutiny.

Symptoms/Signals on the Floor or in the Lab

Identifying the presence of adhesion failure is critical and can manifest through several symptoms during manufacturing or testing processes. Common signals include:

  • Product Appearance:
Visual inspection of transdermal patches may reveal peeling, bubbling, or discoloration.
  • Performance Testing: Reduced adhesion force values below specifications during peel strength tests.
  • Stability Data: Unexpected changes in adhesion properties during accelerated or real-time stability studies.
  • Customer Complaints: Reports of product inefficacy or adverse events potentially linked to poor adhesion.
  • Documenting and analyzing these symptoms promptly is essential for timely action. A systematic logging mechanism should be in place to capture occurrences and serve as a basis for further investigation.

    Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

    Adhesion failure can be multifactorial, arising from one or more issues across the following categories:

    Category Possible Causes
    Materials Quality of adhesives, raw material compatibility, or changes in supplier formulations.
    Method Inadequate mixing techniques, improper application methodologies, or incorrect curing times.
    Machine Equipment malfunctions, calibration issues, or inadequate maintenance leading to variations in process parameters.
    Man Operator error, lack of training, or inadequate understanding of material behavior.
    Measurement Inadequate testing protocols, expired calibration of measuring devices, or improper test execution.
    Environment Incorrect storage conditions, fluctuations in temperature and humidity, or contamination during manufacturing.

    An analysis of these potential causes will aid in narrowing down the focus for investigation. Regular reviews of production logs and deviation reports can facilitate identification of patterns and reoccurring issues.

    Immediate Containment Actions (first 60 minutes)

    Upon detection of adhesion failure, swift containment actions are paramount to mitigate risk. The first 60 minutes should include:

    1. Cease production and isolate affected batches or materials to prevent further use.
    2. Notify relevant stakeholders, including manufacturing, quality assurance, and regulatory affairs teams, about the occurrence.
    3. Document all findings and actions taken in real-time to ensure accuracy.
    4. Evaluate potential risks to patient safety and product quality and initiate an assessment of impacted batches.
    5. Conduct a root cause identification meeting involving cross-functional teams to gather insights and formulate a preliminary plan for investigation.

    Investigation Workflow (data to collect + how to interpret)

    A structured investigation workflow is vital to effectively identify the root cause of adhesion failures. Key steps include:

    1. Assemble a Cross-Functional Investigation Team: Include representatives from manufacturing, quality control, engineering, and regulatory affairs.
    2. Gather Data: Collect detailed records of the production process, including batch records, operator logs, and equipment maintenance records. Specific data points include:
      • Material specifications and certificates of analysis (CoA).
      • In-process testing results.
      • Environmental monitoring logs during production.
      • Training records of operators involved in the batch.
    3. Analyze Data: Conduct a preliminary analysis to identify deviations from expected outcomes or standards. Use trend analysis to spot anomalies.
    4. Document Findings: Maintain a comprehensive investigation report encompassing all collected data and findings.

    Data interpretation should be conducted systematically, employing statistical tools when necessary. Only through rigorous data analysis can one draw accurate conclusions regarding the factors contributing to adhesion failure.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

    Once data is collected, root cause analysis (RCA) methodologies should be employed for deeper understanding:

    • 5-Why Analysis: Utilized for straightforward problems with a suspected direct cause. Continue asking “why” until the fundamental issue is identified.
    • Fishbone Diagram (Ishikawa): Ideal for more complex issues with multiple contributors. Categorize causes into relevant sections (Materials, Method, Machine, etc.) and visually map out relationships.
    • Fault Tree Analysis (FTA): Suitable for highly technical problems where interactions between failures must be understood. This method uses logic diagrams to demonstrate pathways to failure.

    The choice of tool should align with the complexity of the failure and the familiarity of the team with each methodology. Documentation of the analysis process is crucial for inspection readiness.

    CAPA Strategy (correction, corrective action, preventive action)

    The CAPA strategy forms the backbone of any remediation efforts following an adhesion failure investigation:

    • Correction: Implement immediate corrections to affected batches. This may include reprocessing materials or halting distribution.
    • Corrective Action: Address the root cause. This may involve revising material sourcing agreements, enhancing operator training, or recalibrating equipment.
    • Preventive Action: Propose systemic changes to prevent recurrence, such as updated standard operating procedures (SOPs), done through change control processes.

    Document all actions taken in a CAPA report, ensuring it is clear, concise, and maintains compliance with regulatory expectations. Use CAPA as an opportunity to improve overall quality processes.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    A robust control strategy post-investigation is essential to monitor for future adhesion failures effectively:

    • Statistical Process Control (SPC): Implement SPC techniques to monitor adhesion properties continuously. Control charts can help identify trends and variations in process performance.
    • Regular Sampling: Schedule frequent sampling of materials and finished products to ensure compliance with adhesion requirements.
    • Alarm Systems: Set up alerts for deviations from defined thresholds, indicating potential risks to adhesion quality.
    • Verification Activities: Routine audits of production processes should be carried out to confirm ongoing adherence to revised controls.

    Maintaining vigilant oversight ensures that any emergent trends can be addressed before they materialize into significant failures.

    Validation / Re-qualification / Change Control impact (when needed)

    Depending on the investigation findings, validation and re-qualification processes may be necessary, particularly if significant changes were implemented:

    Related Reads

    • Validation: Ensure that any newly introduced materials, methods, or equipment are validated to confirm that they meet quality requirements.
    • Re-qualification: Conduct re-qualification of equipment and processes if they’ve been altered as part of corrective actions.
    • Change Control: All changes necessitated by the investigation should be documented through a formal change control system, ensuring that altered processes are vetted for compliance.

    Proper execution of these processes helps secure compliance with regulatory expectations and assures product quality.

    Inspection Readiness: What Evidence to Show (records, logs, batch docs, deviations)

    When undergoing regulatory inspections, preparation in advance is pivotal. Evidence to demonstrate adherence to quality standards and resolution of prior issues should encompass:

    • Records of Investigations: Include detailed reports reflecting the investigative process, findings, and decisions made.
    • CAPA Documentation: Ensure that all CAPA activities are accurately recorded, including timelines and responsible personnel.
    • Batch Production Records: Maintain clear records of all releasable batches to demonstrate compliance with established specifications.
    • Deviations Log: Keep an up-to-date log of all deviations, providing data on trends, frequency, and actions taken.

    Being thorough in documentation and ready to discuss findings with inspectors showcases a proactive approach to quality management. This diligence greatly aids during FDA, EMA, or MHRA inspections.

    FAQs

    What is the first step when an adhesion failure is identified?

    The first step is to cease production, isolate impacted batches, and notify relevant stakeholders.

    What root cause analysis tool is most effective for a straightforward problem?

    The 5-Why Analysis is often effective for straightforward issues, allowing for quick identification of the root cause.

    How often should control strategies be reviewed?

    Control strategies should be reviewed routinely as part of quality assurance audits and adaptations made as needed.

    What documentation is critical for regulatory inspection readiness?

    Critical documents include investigation reports, CAPA plans, batch production records, and deviations logs.

    When should re-validation be conducted after an adhesion failure?

    Re-validation should be conducted if any significant changes were made to processes, materials, or equipment as corrective measures.

    Are customer complaints considered during investigations?

    Yes, customer complaints provide valuable insights and should be included as part of the data collection for investigations.

    What training is necessary for operators to prevent adhesion failures?

    Operators should receive training on material properties, proper handling, and the significance of adhering to standard operating procedures.

    How can statistical process control help in monitoring adhesion?

    SPC helps identify trends and variations in adhesion properties over time, enabling proactive management of process risks.

    What actions should be taken if an OOS result is obtained?

    Investigate the OOS result thoroughly, analyze potential causes, and implement corrective actions as needed to ensure product quality.

    How can environmental conditions impact adhesion in transdermal patches?

    Environmental conditions such as humidity and temperature can affect the chemical properties of adhesives, impacting adhesion efficacy.

    What role does change control play post-investigation?

    Change control ensures that all modifications made as a result of the investigation are formally reviewed and documented, maintaining compliance with regulatory standards.

    What is the significance of timely documentation during an investigation?

    Timely documentation is essential to ensure accuracy and provide a complete account of events, findings, and actions taken during an investigation.

    Pharma Tip:  Backing Delamination during scale-up: root cause mapping across materials and process